| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| IRMDIRadimed Corporation | 1.3B | 102.57 | 68.38 | 11.71% | 26.31% | 21.54% | 1.35% | 0.00 |
| BRKRBruker Corporation | 7.52B | 49.46 | 65.08 | 13.56% | -0.61% | -0.84% | 1.81% | 1.24 |
| STESTERIS plc | 26.33B | 268.26 | 43.27 | 6.24% | 12.07% | 9.8% | 2.95% | 0.33 |
| FONRFONAR Corporation | 114.98M | 18.64 | 15.15 | 1.43% | 7.08% | 4.62% | 6.48% | 0.24 |
| HYPRHyperfine, Inc. | 100.18M | 1.22 | -2.18 | 16.84% | -378.17% | -149.05% | 0.01 | |
| PACBPacific Biosciences of California, Inc. | 709.48M | 2.35 | -2.20 | -23.19% | -325.8% | -13.95% | 1.33 | |
| IRIXIRIDEX Corporation | 23.21M | 1.35 | -2.50 | -6.17% | -10.04% | -108.67% | 2.21 | |
| MASS908 Devices Inc. | 199.79M | 5.52 | -2.60 | 18.72% | -7.17% | -3.03% | 0.06 |
| Apr 2023 | Apr 2024 | |
|---|---|---|
| Sales/Revenue | 650.8K | 1.88M |
| Revenue Growth % | - | 1.89% |
| Cost of Goods Sold | 536.17K | 985.1K |
| COGS % of Revenue | 0.82% | 0.52% |
| Gross Profit | 114.63K | 897.7K |
| Gross Margin % | 0.18% | 0.48% |
| Gross Profit Growth % | - | 6.83% |
| Operating Expenses | 2.16M | 3.4M |
| OpEx % of Revenue | 3.31% | 1.81% |
| Selling, General & Admin | 1.59M | 2.09M |
| SG&A % of Revenue | 2.44% | 1.11% |
| Research & Development | 26.96K | 90.57K |
| R&D % of Revenue | 0.04% | 0.05% |
| Other Operating Expenses | 538.74K | 1.22M |
| Operating Income | -2.04M | -2.5M |
| Operating Margin % | -3.14% | -1.33% |
| Operating Income Growth % | - | -0.23% |
| EBITDA | -1.85M | -2.33M |
| EBITDA Margin % | -2.84% | -1.24% |
| EBITDA Growth % | - | -0.26% |
| D&A (Non-Cash Add-back) | 195.64K | 176.71K |
| EBIT | -1.64M | -2.32M |
| Net Interest Income | -25.06K | -43.54K |
| Interest Income | 0 | 0 |
| Interest Expense | 25.07K | 43.54K |
| Other Income/Expense | 374.39K | 143.28K |
| Pretax Income | -1.67M | -2.36M |
| Pretax Margin % | -2.56% | -1.25% |
| Income Tax | 0 | 0 |
| Effective Tax Rate % | 1% | 1% |
| Net Income | -1.67M | -2.36M |
| Net Margin % | -2.56% | -1.25% |
| Net Income Growth % | - | -0.41% |
| Net Income (Continuing) | -1.67M | -2.36M |
| Discontinued Operations | 0 | 0 |
| Minority Interest | 0 | 0 |
| EPS (Diluted) | -0.62 | 0.00 |
| EPS Growth % | - | 1% |
| EPS (Basic) | -0.62 | 0.00 |
| Diluted Shares Outstanding | 2.7M | 0 |
| Basic Shares Outstanding | 2.7M | 0 |
| Dividend Payout Ratio | - | - |
| Apr 2023 | Apr 2024 | |
|---|---|---|
| Total Current Assets | 909.3K | 4.73M |
| Cash & Short-Term Investments | 54.1K | 2.31M |
| Cash Only | 54.1K | 2.31M |
| Short-Term Investments | 0 | 0 |
| Accounts Receivable | 567.03K | 1.94M |
| Days Sales Outstanding | 318.02 | 376.78 |
| Inventory | 151.52K | 187.58K |
| Days Inventory Outstanding | 103.15 | 69.5 |
| Other Current Assets | 20.04K | 225.7K |
| Total Non-Current Assets | 473.07K | 451.45K |
| Property, Plant & Equipment | 473.07K | 451.45K |
| Fixed Asset Turnover | 1.38x | 4.17x |
| Goodwill | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Long-Term Investments | 0 | 0 |
| Other Non-Current Assets | 0 | 0 |
| Total Assets | 1.38M | 5.18M |
| Asset Turnover | 0.47x | 0.36x |
| Asset Growth % | - | 2.75% |
| Total Current Liabilities | 3.75M | 2.05M |
| Accounts Payable | 91.09K | 293.91K |
| Days Payables Outstanding | 62.01 | 108.9 |
| Short-Term Debt | 143.35K | 440.45K |
| Deferred Revenue (Current) | 0 | 0 |
| Other Current Liabilities | 32K | 32K |
| Current Ratio | 0.24x | 2.31x |
| Quick Ratio | 0.20x | 2.22x |
| Cash Conversion Cycle | 359.16 | 337.39 |
| Total Non-Current Liabilities | 651.68K | 219.34K |
| Long-Term Debt | 574.56K | 133.98K |
| Capital Lease Obligations | 77.12K | 85.36K |
| Deferred Tax Liabilities | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 |
| Total Liabilities | 4.4M | 2.26M |
| Total Debt | 885.35K | 792.58K |
| Net Debt | 831.26K | -1.52M |
| Debt / Equity | - | 0.27x |
| Debt / EBITDA | - | - |
| Net Debt / EBITDA | - | - |
| Interest Coverage | -81.47x | -57.49x |
| Total Equity | -3.02M | 2.92M |
| Equity Growth % | - | 1.97% |
| Book Value per Share | -1.12 | - |
| Total Shareholders' Equity | -3.02M | 2.92M |
| Common Stock | 2.65K | 3.49K |
| Retained Earnings | -4.67M | -7.03M |
| Treasury Stock | 0 | 0 |
| Accumulated OCI | 0 | 0 |
| Minority Interest | 0 | 0 |
| Apr 2023 | Apr 2024 | |
|---|---|---|
| Cash from Operations | -1.79M | -1.61M |
| Operating CF Margin % | -2.75% | -0.85% |
| Operating CF Growth % | - | 0.1% |
| Net Income | -1.67M | -2.36M |
| Depreciation & Amortization | 195.64K | 176.71K |
| Stock-Based Compensation | 0 | 0 |
| Deferred Taxes | 0 | 0 |
| Other Non-Cash Items | 81.28K | 153.71K |
| Working Capital Changes | -397.62K | 419.95K |
| Change in Receivables | -477.78K | 154.44K |
| Change in Inventory | 116.53K | -36.06K |
| Change in Payables | -33.49K | 202.81K |
| Cash from Investing | -187.89K | -1.65M |
| Capital Expenditures | -217.64K | -121.32K |
| CapEx % of Revenue | 0.33% | 0.06% |
| Acquisitions | - | - |
| Investments | - | - |
| Other Investing | 29.75K | -1.53M |
| Cash from Financing | 1.91M | 5.52M |
| Debt Issued (Net) | - | - |
| Equity Issued (Net) | - | - |
| Dividends Paid | 0 | 0 |
| Share Repurchases | - | - |
| Other Financing | 0 | -224.69K |
| Net Change in Cash | - | - |
| Free Cash Flow | -2.01M | -1.73M |
| FCF Margin % | -3.08% | -0.92% |
| FCF Growth % | - | 0.14% |
| FCF per Share | -0.74 | - |
| FCF Conversion (FCF/Net Income) | 1.07x | 0.68x |
| Interest Paid | 25.07K | 43.54K |
| Taxes Paid | 0 | 0 |
| Metric | 2022 | 2023 |
|---|---|---|
| Return on Equity (ROE) | - | -80.81% |
| Gross Margin | 17.61% | 47.68% |
| Net Margin | -256.27% | -125.34% |
| Debt / Equity | - | 0.27x |
| Interest Coverage | -81.47x | -57.49x |
| FCF Conversion | 1.07x | 0.68x |
| Revenue Growth | - | 189.31% |
Phaos Technology Holdings (Cayman) Limited (POAS) reported $1.9M in revenue for fiscal year 2023. This represents a 189% increase from $0.7M in 2022.
Phaos Technology Holdings (Cayman) Limited (POAS) grew revenue by 189.3% over the past year. This is strong growth.
Phaos Technology Holdings (Cayman) Limited (POAS) reported a net loss of $2.4M for fiscal year 2023.
Phaos Technology Holdings (Cayman) Limited (POAS) has a return on equity (ROE) of -80.8%. Negative ROE indicates the company is unprofitable.
Phaos Technology Holdings (Cayman) Limited (POAS) had negative free cash flow of $1.7M in fiscal year 2023, likely due to heavy capital investments.